| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −1.9× | −1.7× | |
| Price / Book | −22.5× | 2.0× | |
| Price / Sales | 145.4× | 3.9× | |
| Price / Free cash flow | −6.4× | −1.5× | |
| EV / EBITDA | −4.8× | −1.2× | |
| Earnings yield | −52.2% | −14.3% | |
| Free cash flow yield | −15.5% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,288.62 | +3.89% | $1.21T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.70 | +2.33% | $625.85B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $289.49 | +2.41% | $511.56B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $420.62 | +3.38% | $377.55B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.23 | +3.20% | $365.71B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.58 | +2.25% | $283.12B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.75 | +2.92% | $261.71B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $689.61 | +1.51% | $254.98B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $435.22 | +2.42% | $235.29B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.34 | +2.14% | $193.85B | 22.3× | 37.5% | +29.9% |
